Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

133.01 

0.70 0.5%

as of Apr 18 '19

52 Week Range:

91.57 146.10


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations. The Research & Development Solutions segment offers biopharmaceutical development services comprising project management and clinical monitoring, clinical trial support, and strategic planning and design services, as well as clinical trial, genomic, and bioanalytical laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. IQVIA Holdings Inc. serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) -5.49
-4.32
-3.40
-1.33
34.91
36.53
growth rate 0.0% 0.0% 0.0% 100.0% 4.6%
Earnings BIT 599.00
678.00
765.00
785.00
830.00
growth rate 13.2% 12.8% 2.6% 5.7%
Avg.PE 415.37
17.97
114.40
growth rate -95.7% 536.6%
ROA 10.41
7.36
8.14
11.18
10.71
0.92
5.96
1.14
growth rate -29.3% 10.6% 37.4% -4.2% -91.4% 547.8% -80.9%
ROE 2.85
15.64
3.49
growth rate 448.8% -77.7%
ROIC 1.74
15.56
3.28
growth rate 794.3% -78.9%
Cur. Ratio 1.15
1.15
1.31
1.45
1.51
1.23
1.18
1.10
growth rate 0.0% 13.9% 10.7% 4.1% -18.5% -4.1% -6.8%
Quick Ratio 1.03
1.01
1.16
1.28
1.37
1.10
1.05
0.96
growth rate -1.9% 14.9% 10.3% 7.0% -19.7% -4.6% -8.6%
Leverage 2.46
2.80
3.36
growth rate 13.8% 20.0%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 1,020.61
1,200.00
1,741.00
2,144.00
2,463.00
growth rate 17.6% 45.1% 23.2% 14.9%
Acct.Payable 108.74
145.00
250.00
322.00
437.00
growth rate 33.3% 72.4% 28.8% 35.7%
Cur.Assets 2,146.08
2,412.00
3,337.00
3,554.00
3,874.00
growth rate 12.4% 38.4% 6.5% 9.0%
Total Assets 3,295.95
3,926.00
21,208.00
22,857.00
22,549.00
growth rate 19.1% 440.2% 7.8% -1.4%
Cash 867.36
977.00
1,198.00
959.00
891.00
growth rate 12.6% 22.6% -20.0% -7.1%
Cur.Liabilities 1,471.90
1,594.00
2,705.00
3,156.00
3,534.00
growth rate 8.3% 69.7% 16.7% 12.0%
Liabilities 3,999.97
4,262.00
12,348.00
14,613.00
15,595.00
growth rate 6.6% 189.7% 18.3% 6.7%
LT Debt 2,282.60
2,419.00
7,108.00
10,131.00
10,921.00
growth rate 6.0% 193.8% 42.5% 7.8%
Equity -704.06
-564.00
8,633.00
7,995.00
6,714.00
growth rate 0.0% 100.0% -7.4% -16.0%
Common Shares 128.00
128.00
129.00
128.00
131.00
125.00
152.00
222.00
208.00
growth rate 0.0% 0.8% -0.8% 2.3% -4.6% 21.6% 46.1% -6.3%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 83.00
78.00
164.00
369.00
459.00
growth rate -6.0% 110.3% 125.0% 24.4%
Cash From OA 433.00
476.00
860.00
970.00
1,254.00
growth rate 9.9% 80.7% 12.8% 29.3%
FCF per Share 1.88
2.41
3.49
4.26
3.61
3.07
growth rate 28.2% 44.8% 22.1% -15.3% -15.0%
Sale Purchase of Stock 35.00
64.00
97.00
91.00
growth rate 82.9% 51.6% -6.2%
FCF 298.00
85.00
264.00
305.00
349.00
397.00
696.00
601.00
795.00
growth rate -71.5% 210.6% 15.5% 14.4% 13.8% 75.3% -13.7% 32.3%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 4,165.00
4,326.00
6,815.00
9,702.00
10,412.00
growth rate 3.9% 57.5% 42.4% 7.3%
Op.Income 599.00
678.00
765.00
785.00
830.00
growth rate 13.2% 12.8% 2.6% 5.7%
IBT 506.00
547.00
412.00
304.00
343.00
growth rate 8.1% -24.7% -26.2% 12.8%
Net Income 357.00
387.00
72.00
1,277.00
259.00
growth rate 8.4% -81.4% 1,673.6% -79.7%
EPS 1.26
1.39
1.77
2.72
3.08
0.47
5.74
1.24
growth rate 5.0% 27.3% 53.7% 13.2% -84.7% 1,121.3% -78.4%
Gross Profit 1,501.00
1,621.00
2,067.00
3,401.00
3,666.00
growth rate 8.0% 27.5% 64.5% 7.8%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 228.00
209.00
193.00
210.00
212.00
growth rate -8.3% -7.7% 8.8% 1.0%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 2,040.00
2,295.00
2,224.00
2,364.00
2,463.00
growth rate 12.5% -3.1% 6.3% 4.2%
Acct.Payable 322.00
1,985.00
1,941.00
2,060.00
437.00
growth rate 516.5% -2.2% 6.1% -78.8%
Cur.Assets 3,450.00
3,724.00
3,587.00
3,696.00
3,874.00
growth rate 7.9% -3.7% 3.0% 4.8%
Total Assets 22,742.00
23,235.00
22,626.00
22,498.00
22,549.00
growth rate 2.2% -2.6% -0.6% 0.2%
Cash 959.00
960.00
879.00
827.00
891.00
growth rate 0.1% -8.4% -5.9% 7.7%
Cur.Liabilities 2,904.00
3,199.00
3,166.00
3,380.00
3,534.00
growth rate 10.2% -1.0% 6.8% 4.6%
Liabilities 14,384.00
14,782.00
15,012.00
15,038.00
15,595.00
growth rate 2.8% 1.6% 0.2% 3.7%
LT Debt 10,122.00
10,349.00
10,633.00
10,524.00
10,921.00
growth rate 2.2% 2.7% -1.0% 3.8%
Equity 8,109.00
8,196.00
7,364.00
7,215.00
6,714.00
growth rate 1.1% -10.2% -2.0% -6.9%
Common Shares 2.00
10,797.00
10,836.00
10,876.00
3.00
growth rate 539,750.0% 0.4% 0.4% -100.0%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 102.00
88.00
110.00
123.00
138.00
growth rate -13.7% 25.0% 11.8% 12.2%
Cash Dividends
growth rate
Cash From OA 233.00
182.00
311.00
344.00
417.00
growth rate -21.9% 70.9% 10.6% 21.2%
Sale Purchase of Stock 5.00
-106.00
growth rate -100.0%
FCF 131.00
94.00
201.00
221.00
279.00
growth rate -28.2% 113.8% 10.0% 26.2%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 2,161.00
2,563.00
2,567.00
2,594.00
2,688.00
growth rate 18.6% 0.2% 1.1% 3.6%
Op.Income 228.00
209.00
193.00
210.00
212.00
growth rate -8.3% -7.7% 8.8% 1.0%
IBT 92.00
92.00
92.00
53.00
106.00
growth rate 0.0% 0.0% -42.4% 100.0%
Net Income 1,076.00
69.00
61.00
60.00
69.00
growth rate -93.6% -11.6% -1.6% 15.0%
Gross Profit 970.00
911.00
893.00
916.00
946.00
growth rate -6.1% -2.0% 2.6% 3.3%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (44.47)

YOY Growth Grade:

D (44.68)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 107.27 107.27 18.27
EPS / Growth 21.8% 1.24 16.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 43.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 16.2% 27.0% 27.0%
Future PE 18.27 59.85 59.85
Future EPS 5.54 13.55 13.55
Value Price
MOS %
25.03
-81.2%
200.41
50.7%
200.41
50.7%
MOS Price 12.51 100.20 100.20
IRT 18.47 13.24 13.24

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.